Index of medicine substances

Abacavir  •  Antiinfectives for systemic use | Direct acting antivirals | Nucleoside and nucleotide reverse transcriptase inhibitors (J05AF06)

Abacavir + lamivudine  •  Antiinfectives for systemic use | Direct acting antivirals | Antivirals for treatment of HIV infections, combinations (J05AR02)

Abacavir + lamivudine + zidovudine  •  Antiinfectives for systemic use | Direct acting antivirals | Antivirals for treatment of HIV infections, combinations (J05AR04)

Abatacept  •  Antineoplastic and immunomodulating agents | Immunosuppressants | Immunosuppressants | Selective immunosuppressants (L04AA24)

Abciximab  •  Blood and blood forming organs | Antithrombotic agents | Antithrombotic agents | Platelet aggregation inhibitors excl. heparin (B01AC13)

Abemaciclib  •  Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Cyclin-dependent kinase (CDK) inhibitors (L01EF03)

Abiraterone  •  Antineoplastic and immunomodulating agents | Hormone antagonists and related agents | Other hormone antagonists and related agents (L02BX03)

Abrocitinib  •  Dermatologicals | Other dermatological preparations | Other dermatological preparations | Agents for dermatitis, excluding corticosteroids (D11AH08)

Acalabrutinib  •  Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Bruton's tyrosine kinase (BTK) inhibitors (L01EL02)

Acarbose  •  Alimentary tract and metabolism | Blood glucose lowering drugs, excl. insulins | Alpha glucosidase inhibitors (A10BF01)

Aceclofenac  •  Musculo-skeletal system | Antiinflammatory and antirheumatic products | Antiinflammatory and antirheumatic products, non-steroids | Acetic acid derivatives and related substances (M01AB16)

Acemetacin  •  Musculo-skeletal system | Antiinflammatory and antirheumatic products | Antiinflammatory and antirheumatic products, non-steroids | Acetic acid derivatives and related substances (M01AB11)

Acenocoumarol  •  Blood and blood forming organs | Antithrombotic agents | Antithrombotic agents | Vitamin K antagonists (B01AA07)

Acetazolamide  •  Sensory organs | Antiglaucoma preparations and miotics | Carbonic anhydrase inhibitors (S01EC01)

Acetylcholine chloride  •  Sensory organs | Antiglaucoma preparations and miotics | Parasympathomimetics (S01EB09)

Acetylcysteine  •  Respiratory system | Expectorants, excl. combinations with cough suppressants | Mucolytics (R05CB01)

Acetylcysteine + tuaminoheptane sulfate  •  Respiratory system | Decongestants and other nasal preparations for topical use | Sympathomimetics, combinations excl. corticosteroids (R01AB08)

Acetylsalicylic acid  •  Blood and blood forming organs | Antithrombotic agents | Antithrombotic agents | Platelet aggregation inhibitors excl. heparin (B01AC06)

Acetylsalicylic acid + ascorbic acid  •  Nervous system | Other analgesics and antipyretics | Salicylic acid and derivatives (N02BA51)

Acetylsalicylic acid + atorvastatin + ramipril  •  Cardiovascular system | Lipid modifying agents | Lipid modifying agents, combinations | Lipid modifying agents in combination with other drugs (C10BX06)

Acetylsalicylic acid + bisoprolol  •  Cardiovascular system | Beta blocking agents | Beta blocking agents | Beta blocking agents, selective (C07AB57)

Acetylsalicylic acid + caffeine  •  Nervous system | Other analgesics and antipyretics | Salicylic acid and derivatives (N02BA51)

Acetylsalicylic acid + dipyridamole  •  Blood and blood forming organs | Antithrombotic agents | Antithrombotic agents | Platelet aggregation inhibitors excl. heparin (B01AC30)

Acetylsalicylic acid + esomeprazole  •  Blood and blood forming organs | Antithrombotic agents | Antithrombotic agents | Platelet aggregation inhibitors excl. heparin (B01AC56)

Acetylsalicylic acid + paracetamol + caffeine  •  Nervous system | Other analgesics and antipyretics | Salicylic acid and derivatives (N02BA51)

Acetylsalicylic acid + paracetamol + caffeine + chlorpheniramine maleate  •  Nervous system | Other analgesics and antipyretics | Salicylic acid and derivatives (N02BA51)

Acetylsalicylic acid + paracetamol + caffeine + codeine  •  Nervous system | Other analgesics and antipyretics | Salicylic acid and derivatives (N02BA51)

Acetylsalicylic acid + paracetamol + caffeine + codeine + phenobarbital  •  Nervous system | Other analgesics and antipyretics | Salicylic acid and derivatives (N02BA71)

Acetylsalicylic acid + paracetamol + codeine  •  Nervous system | Other analgesics and antipyretics | Salicylic acid and derivatives (N02BA51)

Acetylsalicylic acid + paracetamol + phenobarbital + caffeine + codeine  •  Nervous system | Other analgesics and antipyretics | Salicylic acid and derivatives (N02BA71)